Sanofi
CompanyFranceFounded 2004
Sanofi develops 85 assets, the furthest approved (alirocumab in hypercholesterolemia). Mostly small molecule and vaccine acting on INSR, GLP1R and DPP4; based in France, founded in 2004.
- 85
- Assets
- Furthest stage
- Approved
- 1,033
- Trials
- 254
- Signals
Pipeline
85Inhibits PCSK9, increasing LDL receptor recycling and lowering circulating LDL cholesterol.
Approved, Antibody, PCSK9, hypercholesterolemia, heterozygous familial hypercholesterolemia
Inhibits DPP-4, increasing incretin activity to enhance glucose-dependent insulin secretion and reduce glucagon secretion.
Approved, Small molecule, DPP4, type 2 diabetes, diabetes mellitus (Phase 3)
Approved, not sold in the US, Small molecule, ABCC8, KCNJ11, type 2 diabetes (Phase 3), diabetes mellitus (Phase 3)
82 more assets
Full company profiles: pipeline, trials, funding and people.
Subsidiaries
10Dynavax Technologies Corporation
13 assets, 16 trials
7 assets, 87 trials
6 assets, 44 trials
1 asset, 7 trials
1 asset, 2 trials
1 asset, 1 trial
1 asset
1 asset
3 trials
2 trials
In the full profile
- Evidence behind the mechanisms11
- Trials1,696
- Deals3
- Signals20
- Integrity notices3
- Similar companies6
Papers
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?
ESC Congress 2026 abstract, Oct 26, 2026
ESC Congress 2026 abstract, Oct 26, 2026
ESC Congress 2026 abstract, Oct 26, 2026
High-dose flu vaccine may help more as frailty risk rises
The lancet. Healthy longevity, Sep 17, 2026
medRxiv, Sep 3, 2026
State-of-the-art of the high dose influenza vaccine in Spain
Frontiers in immunology, Jul 15, 2026
ADA Scientific Sessions 2026 abstract, Jun 6, 2026
Impact of Body Mass Index and Gender on Fractional Insulin Clearance in Healthy Individuals
ADA Scientific Sessions 2026 abstract, Jun 6, 2026
Lipid Profiles as Independent Predictors of Glycemic Control
ADA Scientific Sessions 2026 abstract, Jun 5, 2026
PloS one, Apr 21, 2026
Diabetes therapy : research, treatment and education of diabetes and related disorders, Feb 16, 2026
BMJ open, Jan 21, 2026
Journal of clinical hypertension (Greenwich, Conn.), Nov 15, 2025
Circulation, Nov 10, 2025
JAMA cardiology, Sep 1, 2025
The Journal of infectious diseases, Aug 13, 2025
Identification of Earlier Stage Autoimmune Type 1 Diabetes Using Machine Learning Algorithms
ADA Scientific Sessions 2025 abstract, Jun 20, 2025
ADA Scientific Sessions 2025 abstract, Jun 13, 2025